The Rise of Synthetic Drugs: New Challenges for Global Drug Control.

Area of Science:

• Public Health
• Criminology
• Pharmacology

Background:

• The global synthetic drug market is rapidly expanding due to low-cost production, chemical modification, and sophisticated distribution.
• This expansion reshapes drug use patterns and harms, with regional variations like the US opioid crisis, diverse European markets, and medication misuse in China.
• Existing drug control systems exhibit critical gaps in surveillance, regulation, and treatment.

Purpose of the Study:

• To analyze the challenges posed by the expanding synthetic drug market.
• To identify the limitations of current drug control systems.
• To propose strategies for improving drug control and public health responses.

Main Methods:

• Literature review of synthetic drug trends and market dynamics.
• Analysis of regional drug market characteristics and associated harms.
• Assessment of existing drug control policies and their effectiveness.

Main Results:

• Synthetic drugs present a complex and evolving global challenge, necessitating adaptive control strategies.
• Regional drug markets exhibit distinct patterns, requiring tailored interventions.
• Current drug control frameworks are insufficient to address the scale and nature of synthetic drug threats.

Conclusions:

• Strengthening surveillance systems is essential for early detection of new synthetic drugs.
• Developing novel overdose-prevention technologies is critical.
• Enhanced collaboration between healthcare and international bodies, alongside robust early warning systems, is vital for effective drug control.